| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/28/2007 | CN1921892A Lentiviral vector delivery of msp36 for treatment of cancer |
| 02/28/2007 | CN1921886A Methods of modulating cytokine activity, related reagents |
| 02/28/2007 | CN1921884A Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof |
| 02/28/2007 | CN1921883A Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its use for the treatment of angiogenic-related disorders |
| 02/28/2007 | CN1920045A Co-expression carrier and eukaryon expressing carrier capable of inducing cell immune response |
| 02/28/2007 | CN1920041A Reconstruction of HIV-1 Chinese epidemic strain gag gene and recombination DNA vaccine thereof |
| 02/28/2007 | CN1920035A Macaque estradiol acceptor beta gene fragment and application thereof |
| 02/28/2007 | CN1920034A Macaque estradiol acceptor alpha gene fragment and application thereof |
| 02/28/2007 | CN1920033A Portion gene of macaque 5 hydroxytryptamine 2A acceptor and application thereof |
| 02/28/2007 | CN1920032A Portion gene of macaque 5 hydroxytryptamine 1A acceptor and application thereof |
| 02/28/2007 | CN1919873A Fusion albumen containing HSP70 ATPase structure field and mammal p53 albumen and application thereof |
| 02/28/2007 | CN1919344A Boactivity peptide gene therapy plasmid carrier realized by propeptide recombination |
| 02/28/2007 | CN1919343A Boactivity peptide gene therapy method realized by propeptide recombination |
| 02/28/2007 | CN1302115C Buffer solution for electroporation and a method comprising the use of the same |
| 02/28/2007 | CN1302107C Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth |
| 02/28/2007 | CN1302103C CD 19XCD3 specific polypeptides and uses thereof |
| 02/28/2007 | CN1301749C Polyepitope DNA vaccine of anti-simple herpes virus-2 infection and its preparing method |
| 02/27/2007 | US7183402 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/27/2007 | US7183401 Tumor suppressor protein (designated NOEY2) expressed in normal ovarian and breast surface epithelial cells but absent or down-regulated in ovarian and breast cancer cells; vectors, host cells, detection kits |
| 02/27/2007 | US7183400 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 02/27/2007 | US7183379 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/27/2007 | US7183263 protein expression levels higher than linear polyethylenimine alone, and twice that of branched polyethylenimine, but without any significant loss in cell viability; sterols such as cholesterol conjugated via the haloformate ester reaction |
| 02/27/2007 | US7183262 Administering a construct of a polynucleotide linked to a heat-inducible promoter encoding a therapeutic polypeptide at a site at or near the tumor; and applying heat to the site at or near the tumor to express the polypeptide |
| 02/27/2007 | US7183111 Immunomodulatory formulations and methods for use thereof |
| 02/27/2007 | US7183089 Method for enhancing production of isoprenoid compounds |
| 02/27/2007 | US7183079 Expression vector comprising synthetic promoter and nucleotide sequences coding cecropin proteins for use as tools to enhance disease resistance in catfish; bactericides; parasiticides |
| 02/27/2007 | US7183075 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 02/27/2007 | US7183063 Can be used in screening for agents which act as antagonists to MCP-1, MIP-1 alpha and/or RANTES |
| 02/27/2007 | US7183051 Diagnosis and treatment of cancer |
| 02/27/2007 | US7182944 Administering to the subject a nucleic acid encoding a therapeutic agent and a facilitating agent, wherein the nucleic acid encoding a therapeutic agent and the facilitating agent are administered via localized delivery. |
| 02/22/2007 | WO2007022478A2 Transcription factors in neuronal dendrites-dendritic protein synthesis and cell death |
| 02/22/2007 | WO2007022470A2 Methods and compositions for treating neurological disease |
| 02/22/2007 | WO2007022251A2 Prostatic acid phosphatase and prostate cancer |
| 02/22/2007 | WO2007022151A2 Immunization of avians by administration of non-replicating vectored vaccines |
| 02/22/2007 | WO2007022140A2 Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with hsp20 |
| 02/22/2007 | WO2007021938A2 Method of enhancing therapeutic effect of nucleic acids |
| 02/22/2007 | WO2007021896A2 Chemically modified oligonucleotides for use in modulating micro rna and uses thereof |
| 02/22/2007 | WO2007021413A2 Biologic device for regulation of gene expression |
| 02/22/2007 | WO2007020935A1 Therapeutic agent for pain comprising p2y12 receptor and/or p2y14 receptor blocker |
| 02/22/2007 | WO2007020873A1 Nucleic acid for treatment or prevention of immunodeficiency virus infection |
| 02/22/2007 | WO2007019646A1 Liver-directed gene therapy |
| 02/22/2007 | WO2006131562A3 Diagnostic and therapeutic target cdc2l6 gene and proteins for neurodegenerative diseases |
| 02/22/2007 | WO2006125632A3 Agonistic antibodies that bind to the tweak receptor fn14 and thereby modulate adiposity-associated phenotypes as well as their use in therapy |
| 02/22/2007 | WO2006028967A3 Regulation of oncogenes by micrornas |
| 02/22/2007 | WO2006020996A3 Treatment of parkinson's disease and related disorders |
| 02/22/2007 | WO2005120582A3 Compositions and methods for inhibiting expression of hypoxia-inducible genes |
| 02/22/2007 | WO2005089148A3 Delivery of genes encoding short hairpin rna using receptor-specific nanocontainers |
| 02/22/2007 | WO2005070466A3 Liposome composition for delivery of therapeutic agents |
| 02/22/2007 | WO2005062957A3 Compositions and methods for combined therapy of disease |
| 02/22/2007 | WO2004098491A3 METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES |
| 02/22/2007 | WO2003073991A3 Methods to increase or decrease bone density |
| 02/22/2007 | US20070044164 Methods for producing microRNAs |
| 02/22/2007 | US20070044162 Transgenic rat as animal model for human huntingdon's disease |
| 02/22/2007 | US20070044161 RNAi modulation of the Rho-A gene in research models |
| 02/22/2007 | US20070042986 Methods of inhibiting VEGF-C |
| 02/22/2007 | US20070042985 Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field |
| 02/22/2007 | US20070042984 gene expression inhibition; 5'-nucleotide in 5'-ua-3' motifs in antisense strand are 2'-O-methyl modified, and every pyrimidine in sense strand except for deoxythimidine is 2'-O-methyl modified; isolated cells |
| 02/22/2007 | US20070042983 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/22/2007 | US20070042982 Bioinformatically detectable group of novel regulatory bacterial and bacterial associated oligonucleotides and uses thereof |
| 02/22/2007 | US20070042981 Use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 02/22/2007 | US20070042980 Gp131: methods and compositions for treating cancer |
| 02/22/2007 | US20070042979 Oligonucleic acid-bearing composite and pharmaceutical composition containing the composite |
| 02/22/2007 | US20070042978 Nf-hev compositions and methods of use |
| 02/22/2007 | US20070042977 Vaccine |
| 02/22/2007 | US20070042963 Therapeutic peptides |
| 02/22/2007 | US20070042948 Vav inhibition in graft rejection |
| 02/22/2007 | US20070042947 Agents for preventing and/or treating uppper digestive tract disorders |
| 02/22/2007 | US20070042937 Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
| 02/22/2007 | US20070042492 Amino acid sequences for transferring substances of interest from outside medium to inside of cells, specifically cell nuclei; useful for enhancing delivery of drugs into cytoplasm and/or the cell nucleus from the host organism being treated |
| 02/22/2007 | US20070042447 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers (divisional) |
| 02/22/2007 | US20070042446 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 02/22/2007 | US20070042434 Method for identifying tff2 regulating agents and agents identified using said method |
| 02/22/2007 | US20070042416 Dendritic Enriched Secreted Lymphocyte Activation Molecule |
| 02/22/2007 | US20070042347 High throughput biological heart rate monitor that is molecularly determined |
| 02/22/2007 | US20070042050 Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression |
| 02/22/2007 | US20070042047 Vaccines |
| 02/22/2007 | US20070042031 Systems and methods for manufacturing liposomes |
| 02/22/2007 | US20070042029 Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R) |
| 02/22/2007 | US20070041991 amino acid sequence proteins or immunogenic fragments, encoded sequence from isolated nucleic acid; for treating infection caused from Babesiidae; diagnostic test for the detection of nucleic acids, antibodies or antigens of the organism; safe, stable, easily scaleable production; veterinary medicine |
| 02/22/2007 | US20070041990 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/22/2007 | US20070041989 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/22/2007 | US20070041985 Modulation of the poliovirus receptor function |
| 02/22/2007 | US20070041971 Methods for predicting development of auto-immune diseases and treatment of same |
| 02/22/2007 | US20070041968 Methods of inducing an immune response |
| 02/22/2007 | US20070041963 Human secreted proteins |
| 02/22/2007 | US20070041957 Stimulating formation of an inner ear sensory hair cell for treatment of sensorineuronal hearing loss; deafness |
| 02/22/2007 | US20070041953 Smooth Muscle Progenitor Cells |
| 02/22/2007 | US20070041947 Use of a lentiviral vector in the treatment of pain |
| 02/22/2007 | US20070041946 Serotype of adenovirus and uses thereof |
| 02/22/2007 | US20070041945 Novel method for down-regulation of amyloid |
| 02/22/2007 | US20070041944 Treating tumors by ENH dislocation of ID proteins |
| 02/22/2007 | US20070041943 Expression of virus entry inhibitors and recombinant AAV thereof |
| 02/22/2007 | US20070041942 Use of calcium binding proteins to improve cardiac contractile function |
| 02/22/2007 | US20070041941 Nucleic acid sequences encoding and compositions comrpising ige signal peptide and/or il-15 and methods for using the same |
| 02/22/2007 | US20070041939 Modified cytokines for use in cancer therapy |
| 02/22/2007 | US20070041932 Conjugate for gene transfer comprising oligonucleotide and hydrophilic polymer, polyelectrolyte complex micelles formed from the conjugate, and methods for preparation thereof |
| 02/22/2007 | US20070041901 2'-O-methyl substituted nucleic acids specific to prostate specific membrane antigen (PSMA) for use in detection and targeting cancer tissues |
| 02/22/2007 | CA2618995A1 Antagomirs for use in inhibiting mir-122 |
| 02/22/2007 | CA2618508A1 Truncated memapsin 2 for use for treating alzheimer's disease |
| 02/21/2007 | EP1754788A2 Prostate-specific membrane antigen and uses thereof |